BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33283585)

  • 1. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
    Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
    J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.
    Mahmoudi R; Ashraf Mirahmadi-Babaheidri S; Delaviz H; Fouani MH; Alipour M; Jafari Barmak M; Christiansen G; Bardania H
    J Biomater Appl; 2021 Feb; 35(7):743-753. PubMed ID: 32807016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB; Ko YT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
    Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
    Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable and
    Li R; Lin Z; Zhang Q; Zhang Y; Liu Y; Lyu Y; Li X; Zhou C; Wu G; Ao N; Li L
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17936-17948. PubMed ID: 32208630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
    Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and fabrication of functionalized curdlan-curcumin delivery system to facilitate the therapeutic effects of curcumin on breast cancer.
    Ganie SA; Naik RA; Dar OA; Rather LJ; Assiri MA; Li Q
    Int J Biol Macromol; 2024 May; 267(Pt 1):131388. PubMed ID: 38608982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
    Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
    Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
    Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
    J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
    Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
    Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual pharmaceutical compound delivery.
    Nabitabar M; Shaterian M; Danafar H; Enhessari M
    Sci Rep; 2024 May; 14(1):12073. PubMed ID: 38802442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.